Q1 2024 2Seventy Bio Inc Earnings Call Transcript
Good day and thank you for standing by. Welcome to the 2Seventy Bio first quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Jenn Snyder with 2Seventy Bio. Please go ahead.
Thank you, Shannon, and good morning, everyone. Thank you for joining us. This morning, we issued a press release on our first quarter 2024 financial results. The press release can be found in the Investors and Media section of the company's website at 2seventybio.com.
As a reminder, today's discussion will include forward-looking statements related 2Seventy Bio's current plans and expectations, which are subject to certain risks and uncertainties.
These forward-looking statements regarding regarding our strategic plans, timelines and expectations with respect to sales, efficacy and perceived therapeutic benefits of Abecma, the timing and review of additional studies and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |